TaiGen Biopharmaceuticals Holdings Limited (TPEX:4157)

TPEX:4157 Statistics

Total Valuation

TPEX:4157 has a market cap or net worth of TWD 6.53 billion. The enterprise value is 5.70 billion.

Market Cap	6.53B
Enterprise Value	5.70B

Important Dates

The next estimated earnings date is Wednesday, November 12, 2025.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:4157 has 717.84 million shares outstanding. The number of shares has increased by 0.00% in one year.

Current Share Class	717.84M
Shares Outstanding	717.84M
Shares Change (YoY)	+0.00%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	2.61%
Owned by Institutions (%)	2.79%
Float	430.94M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	160.39
PB Ratio	6.71
P/TBV Ratio	6.71
P/FCF Ratio	77.36
P/OCF Ratio	76.88
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-23.52
EV / Sales	140.03
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	67.54

Financial Position

The company has a current ratio of 12.81, with a Debt / Equity ratio of 0.09.

Current Ratio	12.81
Quick Ratio	12.13
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	1.01
Interest Coverage	-118.76

Financial Efficiency

Return on equity (ROE) is -22.59% and return on invested capital (ROIC) is -10.37%.

Return on Equity (ROE)	-22.59%
Return on Assets (ROA)	-10.04%
Return on Invested Capital (ROIC)	-10.37%
Return on Capital Employed (ROCE)	-18.87%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.03
Inventory Turnover	0.41

Taxes

In the past 12 months, TPEX:4157 has paid 237,000 in taxes.

Income Tax	237,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -34.37% in the last 52 weeks. The beta is 0.13, so TPEX:4157's price volatility has been lower than the market average.

Beta (5Y)	0.13
52-Week Price Change	-34.37%
50-Day Moving Average	9.07
200-Day Moving Average	9.69
Relative Strength Index (RSI)	56.63
Average Volume (20 Days)	1,736,260

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:4157 had revenue of TWD 40.68 million and -242.17 million in losses. Loss per share was -0.34.

Revenue	40.68M
Gross Profit	21.42M
Operating Income	-190.61M
Pretax Income	-241.94M
Net Income	-242.17M
EBITDA	-184.46M
EBIT	-190.61M
Loss Per Share	-0.34

Balance Sheet

The company has 913.95 million in cash and 85.59 million in debt, giving a net cash position of 828.36 million or 1.15 per share.

Cash & Cash Equivalents	913.95M
Total Debt	85.59M
Net Cash	828.36M
Net Cash Per Share	1.15
Equity (Book Value)	972.53M
Book Value Per Share	1.35
Working Capital	936.52M

Cash Flow

In the last 12 months, operating cash flow was 84.88 million and capital expenditures -533,000, giving a free cash flow of 84.34 million.

Operating Cash Flow	84.88M
Capital Expenditures	-533,000
Free Cash Flow	84.34M
FCF Per Share	0.12

Margins

Gross Margin	52.65%
Operating Margin	-468.54%
Pretax Margin	-594.70%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	207.33%

Dividends & Yields

TPEX:4157 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.00%
Shareholder Yield	-0.00%
Earnings Yield	-3.71%
FCF Yield	1.29%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:4157 has an Altman Z-Score of 45.69 and a Piotroski F-Score of 2.

Altman Z-Score	45.69
Piotroski F-Score	2